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ABSTRACT
Physical urticaria includes a heterogeneous group
of disorders characterized by the development of ur-
ticarial lesions and/or angioedema after exposure to
certain physical stimuli. The authors present the case
of a child with severe acquired cold urticaria se-
condary to infectious mononucleosis. Avoidance of
exposure to cold was recommended; prophylactic
treatment with ketotifen and cetirizine was begun
and a self-administered epinephrine kit was pres-
cribed. The results of ice cube test and symptoms
significantly improved. Physical urticaria, which in-
volves complex pathogenesis, clinical course and
therapy, may be potentially life threatening. Evalua-
tion and diagnosis are especially important in chil-
dren. To our knowledge this is the first description of
persistent severe cold-induced urticaria associated
with infectious mononucleosis in a child.
Key words: Children. Cold urticaria. Infectious mono-
nucleosis. Physical urticaria.
RESUMEN
La urticaria física incluye un grupo heterogéneo de
trastornos caracterizados por el desarrollo de lesio-
nes de urticaria y/o de angioedema, después de la
exposición a ciertos estímulos físicos. Los autores
presentan un caso clínico de un niño con urticaria al
frío adquirida grave, secundaria a la mononucleosis
infecciosa. Se le recomendó evitar la exposición al
frío; comenzó tratamiento profiláctico con ketotifeno
y cetirizina y se prescribió kit de epinefrina para
auto-administración. La prueba del cubo de hielo y la
sintomatologia tuvieron una mejoría significativa. La
urticaria física, con etiopatogenia, evolución clínica y
terapéutica complejas, puede en ocasiones amena-
zar la vida del paciente, y al tratarse de niños cobra
gran importancia la evaluación y el reconocimiento.
De los casos descritos que tenemos conocimiento
ésta es la primera descripción de la urticaria frío-indu-
cida grave persistente asociada a mononucleosis in-
fecciosa en niños.
Palabras clave: Mononucleosis infecciosa. Pediatría.
Urticaria al frío. Urticaria física.
INTRODUCTION
Physical urticaria is a unique subgroup of chronic
urticaria, characterised by the development of ur-
ticarial lesions and/or angioedema, in exposed skin
areas, after application of the physical stimuli, such
as heat, cold, solar irradiation, water, exercise, pres-
sure and vibration. Although generally benign and
self-limiting, severe systemic reactions are known
life-threatening complications1,2.
The exact prevalence of physical urticaria is un-
known; it is estimated to be low in the general popu-
lation, building up however 10 to 20 %, of all chronic
urticaria forms. Dermatographism is the most fre-
quent type, present in 2 to 5 % of the general popu-
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lation. Heat-induced urticaria, essentially cholinergic
urticaria, represents 2 to 7 % and cold urticaria 3 to
5% of physical urticaria. The rarest forms, with an in-
cidence under 1 %, correspond to pressure, solar, vi-
bratory and aquagenic urticaria1-3.
There are some common particular characteris-
tics: all forms are clinically quantifiable (measurable
stimulus) and reproducible, with well-defined chal-
lenge tests, making diagnosis easier and turning
monitorization of therapy efficacy possible. They are
usually solved in a spontaneous way in time (months
to years, on an average of 5 years), except for the fa-
milial forms; they affect mostly young adults, being
rare at paediatric age; their etiopathogenesis is un-
known1,3.
CASE REPORT
M.C.N., born in September 1990, male, Caucasian,
with a familial and personal history irrelevant, was re-
ferred to our outpatient clinic in May 1997, due to a
clinical history started in August 1996, characterised
by 3 syncope episodes, associated with generalised
urticaria and angioedema, appearing about 3 minutes
after body immersion in sea or river water, episodes
of lip angioedema about 1 to 5 minutes after inges-
ting cold food and also face, hand and leg localised ur-
ticaria after contact with rain. Skin lesions regressed
spontaneously in 30 to 60 minutes, with no other
symptoms, such as respiratory or gastrointestinal.
Eight weeks before the beginning of the mentioned
symptoms, he had a fever episode, with two-week
evolution, accompanied by sore throat, cervical lym-
phadenopathy and hepato-splenomegaly, with myal-
gia and getting tired easily, which he maintained dur-
ing more than 12 months, though softened; at that
time atypical lymphocytes (10.4%) and a positive het-
erophile antibody test were found in the blood tests
performed.
In the Immunoallergy Department of D.Estefânia
Hospital, analytical tests revealed: complete blood
count with monocytosis (9.6 %), relative (57 %) and
absolute lymphocytosis (3.220) and presence of
atypical lymphocytes (4.3 %); positive Epstein-Barr
virus serology with positive EBV-VCA IgM – Viral Cap-
side Antigen (that persisted with low titers for about
1 year), EBV-VCA IgG and EBNA – Epstein-Barr Nu-
clear Antigen; antibodies anti-EA were negative –
Early Antigen; CMV serology with negative IgM and
positive IgG; total IgE 318 IU/ml; IgG, IgA and IgM
immunoglobulins within normal parameters; ne-
gative syphilis serology; negative antinuclear antibo-
dies; negative cold cryoglobulin and agglutinin; se-
dimentation rate, complement (C3, C4, C1q and
CH100), transaminases, protein electrophoresis and
serum immunoelectrophoresis within normal para-
meters.
The presence of cold urticaria was confirmed by
a positive response to the ice cube test: a 28 mm
× 33 mm wheal appeared after application of cold
stimulus (0 to 4 °C) during 1 minute on the child’s
forearm. Measures such as avoidance of cold expo-
sure, including aquatic activities, were recommend-
ed; prophylactic treatment was begun with ketotifen
(2 mg/day) and cetirizine (5 mg/day) and an epineph-
rine auto-injector kit was prescribed.
Two months after the institution of prophylactic
therapy, the ice cube test was repeated, with posi-
tive response after a 3 minute stimulation (wheal –
42 mm × 40 mm). The child maintains symptoms up
to this date (about 8 years), although with significant
clinical improvement, mentioning short periods im-
mersion of distal extremities of superior limbs in cold
water with no induction of skin lesions; ingestion of
cold foods is well tolerated. At the present time the
ice cube test is still positive for a stimulation of
10 minutes or longer; in serum, anti-EBNA is positive.
DISCUSSION
To our knowledge this is the first description of
acquired persistent severe cold-induced urticaria se-
condary to infectious mononucleosis in children,
started at five years of age.
Cold urticaria, first described by Bourdon in 18664,
is characterised by the development of urticaria
and/or angioedema after exposition to cold (aquatic
activities, cold air, rain, snow, ingestion of cold food or
drink or contact with cold objects)1,5,6. Cold urticaria
can be acquired or familial, the inherited form is very
rare and determined by dominant autossomic trans-
mission. Cold urticaria can be classified according to
its response to cold challenge test: if the ice cube test
turns positive, it is primary or secondary, according to
its aetiology; if the response is atypical (late or in a dis-
tant place from where stimulus was applied) or nega-
tive with suggestive clinical symptoms, it is atypical
acquired urticaria1,3,6. Primary or idiopathic acquired ur-
ticaria is the most common form: Neittaanmäki7
found a prevalence of 96 % in 220 patients studied
with cold urticaria, Santaolalla et al8 in a review of
12 paediatric cases found an infection cause in only
one case and Alangari et al9, in a series of 30 children
with cold urticaria didn’t find any secondary cause.
According to several studies symptoms usually
start in children or young adults, with an average age
of 7 to 25 years old5,7-9; appearance at paediatric age,
as in the case reported, is less frequent. Typically,
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cold urticaria lesions show up few minutes after cold
stimulus, disappearing in 30 to 60 minutes; they ap-
pear mainly on the face, hands and legs. Lip, tongue
and pharynx angioedema can occur after ingestion of
cold food or drink. Cardiovascular, respiratory and
gastrointestinal symptoms are often associated5,6.
Cold urticaria can be classified according to the
severity of clinical signs presented in types I to III6.
The child in study presented a type III clinical pattern,
with generalised urticaria and angioedema, associat-
ed to anaphylactic shock symptoms.
The clinical diagnosis of cold urticaria was con-
firmed by the ice cube test, which was strongly posi-
tive, with induction of response after one minute of
stimulus. The time needed for the cold stimulus to
induct positive response presents a predictive value
of the type of clinical pattern1,5; there are an inverse-
ly proportional relation between the time needed
to induct response and the severity of symptoms.
Several studies indicate that severe systemic reac-
tion (type III) occurs more frequently in patients with
positive ice cube test for three minute or shorter
stimuli5,6, such as in the presented case.
Secondary acquired cold urticaria is a rare form
and it is diagnosed in presence of suggestive clinical
history, positive cold stimulation test and evidence of
a causal pathology. Malignancies, systemic leukocy-
toclastic vasculitis and infectious diseases, such as
syphilis and infectious mononucleosis, have been im-
plicated in the aetiology of cold urticaria1,6,7.
As in this case, the existence of a clinical history
compatible with infectious mononucleosis, just be-
fore the appearing of physical urticaria signs, with a
haematological pattern of monocytosis, lymphocyto-
sis and presence of atypical lymphocytes and posi-
tive serology for Epstein-Barr virus, lead to the diag-
nosis of secondary acquired cold urticaria associated
with infectious mononucleosis.
In the table I, a summary of the seven clinical cases,
previously described in literature of cold urticaria associ-
ated with infectious mononucleosis10-15, is presented,
showing the similarities and differences between them.
The first case was reported by Tyson et al in 198110.
Levels of specific anti-EBV antibodies were found
in our patient and in two of the other mentioned pa-
tients10,12; in one patient11 specific anti-EBV antibo-
dies were not investigated.
The mechanism, through which infectious mononu-
cleosis triggers cold urticaria, is unknown. Cold cryo-
globulins and agglutinins can appear during infectious
mononucleosis and have been pointed as eventual
causing factors. However, Kaplan16 demonstrated the
presence of cryoglobulins in 20 out of 21 studied pa-
tients with infectious mononucleosis and none of
these patients exhibited cold sensitivity. Cryoglobulins
were not detected in our child and also in two of the
described patients11,15. Autoimmunity mechanisms
could explain the association between Epstein-Barr
virus, as well as other infectious agents, and the ap-
pearance of cold urticaria6.
Allergol et Immunopathol 2004;32(6):368-71
Morais-Almeida M, et al.— COLD URTICARIA AND INFECTIOUS MONONUCLEOSIS IN CHILDREN370
68
Table I
Cold urticaria associated with infectious mononucleosis
Author Age (years) Sex Atopy Clinical manifestations Duration Ice cube Serology Cryoglobulins(weeks) test to EBV
Tyson et al8 24 M + Urticaria, angioedema, < 7 + + +
wheezing, shock
Barth9 19 F IgE Urticaria < 5 ND ND –
Lemanske et al10 17 M ND Urticaria, angioedema, < 3 + + +
hypocomplementemia
Bonnetblanc et al11 21 M ND Urticaria, angioedema, < 1 + + +
hypocomplementemia
Anderson12 15 M ND Urticaria, angioedema < 28 ND + ND
Wu et al13 26 M + Urticaria, angioedema < 1.5 + + –
Wu et al13 17 M + Urticaria < 3 + + +
Case report 5 M IgE Urticaria, angioedema, (*) + + –
shock
(*) Still symptomatic (after > 7 years – at the moment aged 14 years-old).
ND, not done: information not available from the case report or not performed.
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Our clinical case presents some particularities,
such as the patient’s age, the duration of cold sensi-
tivity and the severity of clinical symptoms. The pa-
tient in study is within paediatric age, contrarily to the
7 described patients10-15, aged between 15 and
26 years old. In all 7 cases the duration of cold ur-
ticaria was transitory (maximum 28 weeks) and pa-
ralleled to the clinical course of infectious mononu-
cleosis; on the opposite, the child we reported had a
much longer clinical evolution, still presenting symp-
toms at the present time. Only one of the cases re-
ferred, reported by Tyson et al10, presented systemic
anaphylaxis, as well as the child we studied, occur-
ring after immersion in sea water.
The incidence of atopy in cold urticaria is similar
to that of general population and atopic patients
show no difference in what concerns the severity or
duration of symptoms6,7. If atopy existence is a factor
that contributes to the development of cold urticaria
in patients with mononucleosis, is still very contro-
versial; in the 7 cases described, 3 of the patients
were atopic and 1 presented high serum levels of
total IgE, like the child in study.
Urticaria and other skin lesions occurs in about
5 % of patients with infectious mononucleosis17, a
reason for which some authors raise the hypothesis
that sensitivity to cold in these patients may be more
frequent that the one mentioned. Since cold urticaria
can be potentially life threatening, it is important that
patients who present urticaria and mononucleosis be
carefully evaluated as to their cold sensitivity.
The main goal of cold urticaria treatment is pre-
venting shock reactions, thus cold avoidance mea-
sures (namely aquatic activities), are fundamental. In
what concerns drug therapy, the most reliable symp-
tomatic control is obtained from H1 antihistaminic.
Recent H1 antihistaminic, such as cetirizine, lorata-
dine and fexofenadine with less sedating effects,
high potency and quick action, are of first choice8,18.
Therapeutic efficacy of ketotifen was also docu-
mented19, including a double-blind study performed
in children with cold urticaria20. The association of
H2 antagonists with H1 antagonists, as well as do-
xepin, are other therapeutic alternatives21,22.
Patients with type II (generalized urticaria/an-
gioedema) or type III clinical patterns or positive ice
cube test after 3 minutes or less of stimulation, are
candidates for prophylactic therapy5. Serial use of
ice cube test is recommended to evaluate the effica-
cy of the treatment5,6; in the child in study, we veri-
fied that there was an improvement in test respon-
siveness and a significant clinical amelioration.
The clinical case here presented stresses the im-
portance of diagnosis of cold urticaria in children. This
entity thus rare in this age group can be related to se-
vere forms. Counselling, preventive and emergency
medical therapy may be lifesaving for these children.
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